Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0420 Transporter Info | ||||
Gene Name | SLC5A11 | ||||
Transporter Name | Sodium/myo-inositol cotransporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg04022912) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.53E-08; Z-score: -1.51E+00 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 8.33E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg06028605) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.49E+00 | Statistic Test | p-value: 5.52E-08; Z-score: 1.14E+00 | ||
Methylation in Case |
2.52E-01 (Median) | Methylation in Control | 1.69E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 1.32E-05; Z-score: 6.84E-01 | ||
Methylation in Case |
2.15E-01 (Median) | Methylation in Control | 1.89E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg01435766) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 6.59E-05; Z-score: 7.64E-01 | ||
Methylation in Case |
8.96E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.70E+00 | Statistic Test | p-value: 1.37E-12; Z-score: -2.26E+01 | ||
Methylation in Case |
2.98E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg04022912) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 2.05E-03; Z-score: -5.41E+00 | ||
Methylation in Case |
5.98E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg04399565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -3.09E+00 | Statistic Test | p-value: 6.99E-14; Z-score: -2.28E+01 | ||
Methylation in Case |
2.30E-01 (Median) | Methylation in Control | 7.10E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.24E+00 | Statistic Test | p-value: 1.94E-10; Z-score: -9.53E+00 | ||
Methylation in Case |
2.10E-01 (Median) | Methylation in Control | 4.71E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 1.50E-10; Z-score: -2.41E+00 | ||
Methylation in Case |
6.41E-01 (Median) | Methylation in Control | 7.51E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg06028605) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.35E+00 | Statistic Test | p-value: 3.78E-05; Z-score: 8.63E-01 | ||
Methylation in Case |
2.04E-01 (Median) | Methylation in Control | 1.52E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 9.99E-21; Z-score: -3.40E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 4.96E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg04399565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 3.96E-07; Z-score: -1.36E+00 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 6.43E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg02428538) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.18E-03; Z-score: -1.05E+00 | ||
Methylation in Case |
9.10E-01 (Median) | Methylation in Control | 9.45E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg01435766) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 5.74E-03; Z-score: 2.91E-01 | ||
Methylation in Case |
6.39E-02 (Median) | Methylation in Control | 5.61E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 9.10E-10; Z-score: -2.34E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg04022912) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.49E-02; Z-score: -3.43E-01 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg04399565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 2.54E-07; Z-score: -1.87E+00 | ||
Methylation in Case |
5.84E-01 (Median) | Methylation in Control | 7.89E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 4.65E-04; Z-score: -9.82E-01 | ||
Methylation in Case |
4.92E-01 (Median) | Methylation in Control | 5.82E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A11 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg01435766) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 2.93E-02; Z-score: -4.81E-01 | ||
Methylation in Case |
6.80E-02 (Median) | Methylation in Control | 9.83E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Moderate/moderate hypermethylation of SLC5A11 in colorectal cancer than that in healthy individual/adjacent tissue | ||||
Studied Phenotype |
Colorectal cancer [ICD-11:2B91] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.008540784; Fold-change: 0.236222994; Z-score: 1.285241014 | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value: 0.022796826; Fold-change: 0.283624798; Z-score: 1.912490742 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in depression | [ 5 ] | |||
Location |
5'UTR (cg06028605) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 3.02E-02; Z-score: 6.09E-01 | ||
Methylation in Case |
3.68E-01 (Median) | Methylation in Control | 3.13E-01 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.60E-07; Z-score: -1.46E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 8.04E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg06028605) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 3.12E-03; Z-score: 1.02E+00 | ||
Methylation in Case |
5.32E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg04399565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 1.14E-08; Z-score: -1.76E+00 | ||
Methylation in Case |
5.52E-01 (Median) | Methylation in Control | 6.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg00339695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 4.44E-05; Z-score: -1.12E+00 | ||
Methylation in Case |
4.20E-01 (Median) | Methylation in Control | 5.29E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A11 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg06593603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.69E+00 | Statistic Test | p-value: 5.28E-11; Z-score: -3.03E+00 | ||
Methylation in Case |
3.25E-01 (Median) | Methylation in Control | 5.51E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A11 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg01435766) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.56E+00 | Statistic Test | p-value: 3.27E-07; Z-score: 1.74E+00 | ||
Methylation in Case |
4.72E-01 (Median) | Methylation in Control | 3.02E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg06028605) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 1.07E-04; Z-score: 1.21E+00 | ||
Methylation in Case |
4.32E-01 (Median) | Methylation in Control | 3.13E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.63E-04; Z-score: -1.18E+00 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 8.42E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg04399565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 1.24E-03; Z-score: -1.13E+00 | ||
Methylation in Case |
6.84E-01 (Median) | Methylation in Control | 7.51E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.99E-02; Z-score: -4.49E-01 | ||
Methylation in Case |
5.49E-01 (Median) | Methylation in Control | 5.71E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A11 in HIV infection | [ 7 ] | |||
Location |
Body (cg01435766) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 1.88E-03; Z-score: 8.92E-01 | ||
Methylation in Case |
1.01E-01 (Median) | Methylation in Control | 7.82E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in lung adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg06028605) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 5.10E-04; Z-score: 3.67E+00 | ||
Methylation in Case |
3.53E-01 (Median) | Methylation in Control | 2.58E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in lung adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg00339695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 3.42E-02; Z-score: 1.15E+00 | ||
Methylation in Case |
7.14E-01 (Median) | Methylation in Control | 6.44E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in papillary thyroid cancer | [ 9 ] | |||
Location |
5'UTR (cg26870567) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.26E-04; Z-score: -5.02E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.96E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 3.50E-18; Z-score: -3.92E+00 | ||
Methylation in Case |
4.26E-01 (Median) | Methylation in Control | 6.38E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg04399565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 3.71E-07; Z-score: -1.56E+00 | ||
Methylation in Case |
7.02E-01 (Median) | Methylation in Control | 8.02E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in pancretic ductal adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg12122597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.67E+00 | Statistic Test | p-value: 1.81E-16; Z-score: 2.32E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 2.36E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in pancretic ductal adenocarcinoma | [ 10 ] | |||
Location |
Body (cg09951201) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 8.64E-08; Z-score: -1.64E+00 | ||
Methylation in Case |
6.75E-01 (Median) | Methylation in Control | 8.12E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A11 in pancretic ductal adenocarcinoma | [ 10 ] | |||
Location |
Body (cg03711791) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 7.84E-05; Z-score: 1.05E+00 | ||
Methylation in Case |
7.72E-01 (Median) | Methylation in Control | 7.14E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A11 in pancretic ductal adenocarcinoma | [ 10 ] | |||
Location |
3'UTR (cg12504828) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.04E-03; Z-score: 4.97E-01 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A11 in pancretic ductal adenocarcinoma | [ 10 ] | |||
Location |
3'UTR (cg06912964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.82E-02; Z-score: 3.71E-01 | ||
Methylation in Case |
7.41E-01 (Median) | Methylation in Control | 7.24E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in prostate cancer | [ 11 ] | |||
Location |
TSS1500 (cg26735834) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 3.68E-03; Z-score: 4.43E+00 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A11 in prostate cancer | [ 11 ] | |||
Location |
Body (cg00691874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 2.45E-02; Z-score: 2.98E+00 | ||
Methylation in Case |
7.73E-01 (Median) | Methylation in Control | 6.33E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A11 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 9.46E-03; Z-score: -2.92E-01 | ||
Methylation in Case |
6.11E-01 (Median) | Methylation in Control | 6.40E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Myxopapillary ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC5A11 in myxopapillary ependymoma than that in healthy individual | ||||
Studied Phenotype |
Myxopapillary ependymoma [ICD-11:2A00.5] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.005338976; Fold-change: 0.209210184; Z-score: 1.181585542 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Oligodendroglial tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC5A11 in oligodendroglial tumour than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglial tumour [ICD-11:2A00.Y1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 7.02E-05; Fold-change: 0.210630745; Z-score: 4.191537336 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Spinal ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC5A11 in spinal ependymoma than that in healthy individual | ||||
Studied Phenotype |
Spinal ependymoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.02E-07; Fold-change: 0.225515591; Z-score: 1.208291051 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Brain neuroblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC5A11 in brain neuroblastoma than that in healthy individual | ||||
Studied Phenotype |
Brain neuroblastoma [ICD-11:2A00.11] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.88E-09; Fold-change: -0.269367273; Z-score: -1.664765767 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Uterine carcinosarcoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC5A11 in uterine carcinosarcoma than that in healthy individual | ||||
Studied Phenotype |
Uterine carcinosarcoma [ICD-11:2B5F] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.75E-05; Fold-change: -0.298966361; Z-score: -2.197751588 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC5A11 in melanoma than that in healthy individual | ||||
Studied Phenotype |
Melanoma [ICD-11:2C30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.000768166; Fold-change: -0.303836643; Z-score: -2.0125068 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Multilayered rosettes embryonal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC5A11 in multilayered rosettes embryonal tumour than that in healthy individual | ||||
Studied Phenotype |
Multilayered rosettes embryonal tumour [ICD-11:2A00.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 7.86E-11; Fold-change: -0.309568774; Z-score: -2.012368811 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Liver cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC5A11 in liver cancer than that in adjacent tissue | ||||
Studied Phenotype |
Liver cancer [ICD-11:2C12] | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value: 3.60E-08; Fold-change: -0.215954581; Z-score: -1.914767677 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.